Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Hendlisz

Showing results (81-90 of 140) with videos related to

Pageof 14
Sort By:
Surgery|October 17, 2025
Deep epigastric lymph node involvement in patients with ovarian and colorectal peritoneal metastasis: A prospective pilot studyAntoine El Asmar, Charif Khaled, Isabelle Veys, et al.
Diagnostics (Basel, Switzerland)|April 13, 2024
Development of Clinical Radiomics-Based Models to Predict Survival Outcome in Pancreatic Ductal Adenocarcinoma: A Multicenter Retrospective StudyAyoub Mokhtari, Roberto Casale, Zohaib Salahuddin, et al.
Cancer Treatment Reviews|April 12, 2020
Imaging and clinical correlates with regorafenib in metastatic colorectal cancerKhurum Khan, Stefano Cascinu, David Cunningham, et al.
EJNMMI Research|November 18, 2024
Evolution of dosimetric parameters through PRRT and potential impact on clinical practice: data from the prospective phase II LUMEN studyRachele Danieli, Magdalena Mileva, Gwennaëlle Marin, et al.
Clinical Nutrition ESPEN|August 30, 2020
Fat density is a novel prognostic marker in patients with esophageal cancerMaëlle Anciaux, André Van Gossum, Cynthia Wenglinski, et al.
Seminars in Oncology|January 10, 2006
Correlation between the response to cetuximab alone or in combination with irinotecan and the activated/phosphorylated epidermal growth factor receptor in metastatic colorectal cancerNicola Personeni, Alain Hendlisz, Julien Gallez, et al.
The Oncologist|May 2, 2007
Safety, pharmacokinetics, and preliminary antitumor activity of sorafenib: a review of four phase I trials in patients with advanced refractory solid tumorsDirk Strumberg, Jeffrey W Clark, Ahmad Awada, et al.
World Journal of Gastroenterology|September 2, 2015
Radioembolisation and portal vein embolization before resection of large hepatocellular carcinomaFikri Bouazza, Arthur Poncelet, Camilo Alejandro Garcia, et al.
Journal of Surgical Oncology|October 30, 2016
Salvage esophagectomy after failure of definitive radiochemotherapy for esophageal cancerEleonora Farinella, Adonis Safar, Haydar A Nasser, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 28, 2022
Tumor biology reflected by histological growth pattern is more important than surgical margin for the prognosis of patients undergoing resection of colorectal liver metastasesAli Bohlok, Lisa Inchiostro, Valerio Lucidi, et al.
Pageof 14

Showing results (81-90 of 140) with videos related to

Sort By:
Pageof 14
Surgery|October 17, 2025
Deep epigastric lymph node involvement in patients with ovarian and colorectal peritoneal metastasis: A prospective pilot studyAntoine El Asmar, Charif Khaled, Isabelle Veys, et al.
Diagnostics (Basel, Switzerland)|April 13, 2024
Development of Clinical Radiomics-Based Models to Predict Survival Outcome in Pancreatic Ductal Adenocarcinoma: A Multicenter Retrospective StudyAyoub Mokhtari, Roberto Casale, Zohaib Salahuddin, et al.
Cancer Treatment Reviews|April 12, 2020
Imaging and clinical correlates with regorafenib in metastatic colorectal cancerKhurum Khan, Stefano Cascinu, David Cunningham, et al.
EJNMMI Research|November 18, 2024
Evolution of dosimetric parameters through PRRT and potential impact on clinical practice: data from the prospective phase II LUMEN studyRachele Danieli, Magdalena Mileva, Gwennaëlle Marin, et al.
Clinical Nutrition ESPEN|August 30, 2020
Fat density is a novel prognostic marker in patients with esophageal cancerMaëlle Anciaux, André Van Gossum, Cynthia Wenglinski, et al.
Seminars in Oncology|January 10, 2006
Correlation between the response to cetuximab alone or in combination with irinotecan and the activated/phosphorylated epidermal growth factor receptor in metastatic colorectal cancerNicola Personeni, Alain Hendlisz, Julien Gallez, et al.
The Oncologist|May 2, 2007
Safety, pharmacokinetics, and preliminary antitumor activity of sorafenib: a review of four phase I trials in patients with advanced refractory solid tumorsDirk Strumberg, Jeffrey W Clark, Ahmad Awada, et al.
World Journal of Gastroenterology|September 2, 2015
Radioembolisation and portal vein embolization before resection of large hepatocellular carcinomaFikri Bouazza, Arthur Poncelet, Camilo Alejandro Garcia, et al.
Journal of Surgical Oncology|October 30, 2016
Salvage esophagectomy after failure of definitive radiochemotherapy for esophageal cancerEleonora Farinella, Adonis Safar, Haydar A Nasser, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 28, 2022
Tumor biology reflected by histological growth pattern is more important than surgical margin for the prognosis of patients undergoing resection of colorectal liver metastasesAli Bohlok, Lisa Inchiostro, Valerio Lucidi, et al.
Pageof 14